Your account is not claimed yet. You can sign up with ORCID to claim your account.

James Cheng Chung Wei (James Cheng-Chung Wei, J C-C Wei)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 29

Top Venues

Annals of the rheumatic diseases

RMD open

The Journal of rheumatology

QJM : monthly journal of the Association of Physicians

This page only lists publications with an associated author ORCID identifier.

Publications

Jih-Jin Tsai, Li-Teh Liu, Chun-Hong Chen, Liang-Jen Chen, Shiow-Ing Wang, James Cheng Chung Wei
COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs. RMD open 9 (3) (2023)
Jin-Xian Huang, James Cheng Chung Wei
Postvaccination Acute Exacerbations of Idiopathic Pulmonary Fibrosis? American journal of respiratory and critical care medicine 206 (7) (2022)
Wei Min Chu, James Cheng Chung Wei
Comment on short- and long-term prognosis of glycemic control in COVID-19 patients with type 2 diabetes. QJM : monthly journal of the Association of Physicians 115 (8) (2022)
James Cheng Chung Wei, Tae Hwan Kim, Kishimoto Mitsumasa, Naoki Ogusu, Haeyoun Jeong, Shigeto Kobayashi
Response to: 'Correspondence on 'Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial'' by Zhao and Huang. Annals of the rheumatic diseases (2021)
Weijie Wang, Yung-Heng Lee, James Cheng Chung Wei
Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial'. Annals of the rheumatic diseases (2021)
Jen-Wen Ma, James Cheng Chung Wei
Correspondence on: 'Antidepressants and risk of sudden sensorineural hearing loss'. International journal of epidemiology 50 (5) (2021)
Zhixiu Li, Xin Wu, Paul J Leo, Erika De Guzman, Nurullah Akkoc, Maxime Breban, Gary John Macfarlane, Mahdi Mahmoudi, Helena Marzo-Ortega, Lisa K Anderson, Lawrie Wheeler, Chung-Tei Chou, Andrew A Harrison, Simon M Stebbings, Gareth T Jones, So-Young Bang, Geng Wang, Ahmadreza Jamshidi, Elham Farhadi, Jing Song, Li Lin, Mengmeng Li, James Cheng Chung Wei, Nicholas G Martin, Margaret J Wright, Min Jae Lee, Yuqin Wang, Jian Zhan, Jin-San Zhang, Xiaobing Wang, Zi-Bing Jin, Michael H Weisman, Lianne S Gensler, Michael M Ward, Mohammad Hossein Rahbar, Laura Diekman, Tae Hwan Kim, John D Reveille, Bryan Paul Wordsworth, Huji Xu, Matthew A Brown, null null
Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis. Annals of the rheumatic diseases 80 (9) (2021)
Yun-Tzu Liang, Chih-Jung Yeh, Jing-Yang Huang, James Cheng Chung Wei
Epidemiology of hidradenitis suppurativa in Taiwan: A 14-year nationwide population-based study. The Journal of dermatology 48 (5) (2021)
Xiao-Huan Chen, Fang-Xiao Zhu, Hsin-Hua Chen, James Cheng Chung Wei
Response to: 'Correspondence on 'Risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anaemia: a nationwide French study'' by Maquet et al. Annals of the rheumatic diseases (2021)
Jin-Xian Huang, Pui-Ying Leong, James Cheng Chung Wei
Correspondence on 'Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort' by Micheroli et al. Annals of the rheumatic diseases (2020)
James Cheng Chung Wei, Fang Xiao Zhu, Jing-Yang Huang
Response to: 'High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?' by Inanc et al. Annals of the rheumatic diseases (2020)
Fang Xiao Zhu, Jing-Yang Huang, James Cheng Chung Wei
Response to: 'Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: population-based cohort study' by Goulielmos and Zervou. Annals of the rheumatic diseases (2020)
Chen-Yu Wei, Yung-Heng Lee, James Cheng Chung Wei
Comment on: 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Gossec et al. Annals of the rheumatic diseases (2020)
Fang Xiao Zhu, Jing-Yang Huang, Wen Qingqing, James Cheng Chung Wei
Response to: 'Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a need for a more accurate control group?' by Mertz and Arnaud. Annals of the rheumatic diseases (2020)
Ping-Hao Chiang, Po-Chung Ju, Yun-Chi Chiang, James Cheng Chung Wei
Correspondence on 'Incidence trend of five common musculoskeletal disorders from 1990 to 2017 at the global, regional and national level: results from the global burden of disease study 2017'. Annals of the rheumatic diseases (2020)
Acer I-Hung Chen, Sheng-Chieh Lin, James Cheng Chung Wei
Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al. Annals of the rheumatic diseases (2020)
Hann-Ziong Yueh, Chih-Jung Yeh, James Cheng Chung Wei
Correspondence to 'Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study' by Li et al. Annals of the rheumatic diseases (2020)
Po-Ke Hsu, Yung-Heng Lee, James Cheng Chung Wei
Confounding by indication and ethnicity difference? Comment on 'Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data'. Annals of the rheumatic diseases (2020)
Han-You Mo, Xiao-Huan Chen, James Cheng Chung Wei, Hsin-Hua Chen
Response to: 'Correspondence on 'Increased risk of systemic lupus erythematosus in patients with autoimmune haemolytic anaemia: a nationwide population-based cohort study'' by Goulielmos and Zervou. Annals of the rheumatic diseases (2020)
Xiao-Huan Chen, Chih-Jung Yeh, Han-You Mo, James Cheng Chung Wei
Comment on Ye et al 'Presence of respiratory failure of COVID-19 infection in rheumatism patients in Wuhan, China'. Annals of the rheumatic diseases (2020)
Xiao-Huan Chen, James Cheng Chung Wei, Han-You Mo, Hsin-Hua Chen
Response to: 'Correspondence on 'Risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anaemia: a nationwide French study'' by Maquet et al. Annals of the rheumatic diseases (2020)
Han-You Mo, James Cheng Chung Wei, Xiao-Huan Chen, Hsin-Hua Chen
Increased risk of systemic lupus erythematosus in patients with autoimmune haemolytic anaemia: a nationwide population-based cohort study. Annals of the rheumatic diseases (2020)
Kevin Sheng-Kai Ma, James Cheng Chung Wei, Wen-Hung Chung
Correspondence to 'Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data'. Annals of the rheumatic diseases (2020)
Wen Jie Zheng, Pui-Ying Leong, James Cheng Chung Wei
Correspondence to 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study'. Annals of the rheumatic diseases (2020)
Bo-Yao Wu, Chi-Ho Chan, James Cheng Chung Wei
Correspondence to 'Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases'. Annals of the rheumatic diseases (2020)
Yun-Tzu Liang, Pui-Ying Leong, James Cheng Chung Wei
Questions on the Bidirectional Relationship Between Primary Sjögren Syndrome and Non-Hodgkin Lymphoma. The Journal of rheumatology 48 (4) (2020)
Fang-Xiao Zhu, Jing-Yang Huang, Qing-Qing Wen, James Cheng Chung Wei
Response to 'Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura' by Xie and Zhang. Annals of the rheumatic diseases (2020)
Han-You Mo, James Cheng Chung Wei, Xiao-Huan Chen, Hsin-Hua Chen
Response to: 'Correspondence on 'Increased risk of systemic lupus erythematosus in patients with autoimmune haemolytic anaemia'' by Huang and Zhang. Annals of the rheumatic diseases (2020)
Po-Cheng Hung, Da-Hung Lin, Amy Ker, Chieh-Chun Yang, Hung-Wan Chien, James Cheng Chung Wei
Correspondence on 'Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study'. Annals of the rheumatic diseases (2020)

James Cheng Chung Wei.css-eqlu8i{font-size:small;padding-left:4px;} (James Cheng-Chung Wei, J C-C Wei)

Publication Activity (10 Years)

Top Topics

Top Venues

James Cheng Chung Wei (James Cheng-Chung Wei, J C-C Wei)